The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Whole exome sequencing (WES) of metastatic leiomyosarcoma (LMS) and liposarcoma (LPS) and correlation of genomic aberrations with clinical outcomes in the phase III randomized trial of trabectedin (T) vs. dacarbazine (D).
 
Gurpreet Kapoor
Employment - LabConnect
Research Funding - Janssen Research & Development (Inst)
 
Weimin Li
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Dong Shen
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Roland Elmar Knoblauch
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Michael Gormley
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
George C. Wang
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Deborah S. Ricci
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Michael P. Smith
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Clifford Motley
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Sigrid Malbrain
Employment - Janssen Research & Development
Stock and Other Ownership Interests - Johnson & Johnson
 
Robert G. Maki
Honoraria - Lilly; Springer; Wiley
Consulting or Advisory Role - AADi; American Board of Internal Medicine (ABIM); Arcus Ventures; Bayer; Deciphera; Eisai; Immune Design; Karyopharm Therapeutics; Lilly/ImClone; Presage Biosciences; SARC: Sarcoma Alliance for Research though Collaboration; TRACON Pharma
Research Funding - Daiichi Sankyo (Inst); Immune Design (Inst); Immunocore (Inst); Lilly (Inst); Presage Biosciences (Inst); Regeneron (Inst); TRACON Pharma (Inst); Xencor (Inst)
Patents, Royalties, Other Intellectual Property - Uptodate: I write and edit chapters for their online text book.
Travel, Accommodations, Expenses - TRACON Pharma
 
Margaret vonMehren
Honoraria - Deciphera
Consulting or Advisory Role - Blueprint Medicines; Deciphera
Research Funding - Blueprint Medicines (Inst); Deciphera (Inst); Immune Design (Inst); Karyopharm Therapeutics (Inst); Novartis (Inst)
Travel, Accommodations, Expenses - Deciphera
 
Shreyaskumar Patel
Honoraria - CytRx Corporation; Epizyme; Immune Design; Janssen Research & Development; Lilly; Novartis
Consulting or Advisory Role - CytRx Corporation; Immune Design; Janssen Research & Development; Lilly; Novartis
Research Funding - Blueprint Medicines (Inst); Eisai (Inst); Janssen Research & Development (Inst); Morphotek (Inst)
 
George D. Demetri
Leadership - Blueprint Medicines
Stock and Other Ownership Interests - Bessor Pharma; Blueprint Medicines; Caris Life Sciences; Champions Oncology; G1 Therapeutics; N-of-One
Consulting or Advisory Role - Adaptimmune; Bayer; Blueprint Medicines; Caris Life Sciences; Daiichi Sankyo; Eisai; EMD Serono; G1 Therapeutics; Genocea Biosciences; Janssen Oncology; Kolltan Pharmaceuticals; Kyocera; Lilly; Nektar; Novartis; Pfizer; PharmaMar; Polaris; Sanofi; WIRB-Copernicus Group; ZIOPHARM Oncology
Research Funding - Abbvie (Inst); Janssen Oncology (Inst)
Patents, Royalties, Other Intellectual Property - Patent on use of imatinib for GIST, receive minor royalty payment from Dana-Farber after license between Dana-Farber and Novartis